|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112 - 10339
|
$257,863
|
$12,893
|
Abnet, Christian
|
DCEG (NCI)
|
|
Aerobic Exercise for Smokers with Depressive Symptomatology
|
5R01CA173551-03
|
$556,620
|
$556,620
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Defining mechanisms of cancer chemoresistance and metastasis
|
5R00CA172697-03
|
$249,000
|
$124,500
|
ACHARYYA, SWARNALI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
1U01CA190234-01
|
$667,612
|
$667,612
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
1U24CA194354-01
|
$715,149
|
$357,575
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$73,720
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SON and the MALAT1 locus in chromatin interaction and metastasis gene regulation
|
1R21CA185818-01A1
|
$197,164
|
$197,164
|
AHN, ERIN
|
UNIVERSITY OF SOUTH ALABAMA
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
$43,005
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$871,993
|
$69,759
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
|
5P01CA066726-18
|
$1,182,811
|
$1,182,811
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-03
|
$357,673
|
$357,673
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S1
|
$34,031
|
$4,424
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S2
|
$250,000
|
$32,500
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-07S3
|
$124,997
|
$16,250
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-07
|
$1,495,000
|
$194,350
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$129,586
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Southeast Michigan Community Network Program
|
3U54CA153606-05S2
|
$256,783
|
$38,517
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Unraveling Genetic Determinants of Lung Cancer Risk in African Americans
|
5K07CA172294-03
|
$160,123
|
$160,123
|
ALDRICH, MELINDA
|
VANDERBILT UNIVERSITY
|
|
Clinical Support
|
ZIE BC 011653
|
$18,022
|
$15,318
|
Alewine, Christine
|
CCR (NCI)
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$17,178
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
$8,325
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
$154,701
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Lung cancer heterogeneity and its impact on drug resistance.
|
5R01CA133253-06
|
$191,002
|
$191,002
|
ALTSCHULER, STEVEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$5,000
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$12,445
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Convergence of CREB and MYC Pathways in Oncogenesis.
|
5R00CA157954-04
|
$249,000
|
$74,700
|
AMELIO, ANTONIO
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeted Platinates/siRNA Combination Therapy for Resistant Lung Cancer
|
5R21CA179652-02
|
$202,928
|
$202,928
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Obesity and mortality after breast cancer diagnosis by race/ethnicity in the WHI
|
3UM1CA173642-03S1
|
$113,842
|
$18,215
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-03
|
$2,539,856
|
$406,377
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
LGBT Adults and Tobacco Stigma: A Qualitative Study
|
1R01CA190238-01A1
|
$392,409
|
$392,409
|
ANTIN, TAMAR
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
Translating Research into Systemic Interventions for Tobacco Cessation
|
5K07CA140236-05
|
$169,560
|
$169,560
|
APOLLONIO, DOROTHY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Reversing Cellular immortality in cancer
|
1R35CA197563-01
|
$632,529
|
$189,759
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$5,500
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$13,746
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$21,997
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$17,446
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$802,227
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Defining a Molecularly Distinct Subtype of Non Small Cell Lung Cancer
|
5F30CA168264-03
|
$37,020
|
$37,020
|
AUGUSTYN, ALEXANDER
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and t
|
1R01CA193698-01
|
$355,706
|
$355,706
|
AVANTAGGIATI, MARIA
|
GEORGETOWN UNIVERSITY
|
|
Linking State Registry and All Payer Claims Data to Study Cancer Care
|
5R21CA172892-03
|
$80,385
|
$20,096
|
AYANIAN, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
Modulation of the Immune System as a Strategy to Treat EGFR Mutant Lung Adenocarc
|
1F31CA203488-01
|
$27,768
|
$27,768
|
AYENI, DEBORAH
|
YALE UNIVERSITY
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-04
|
$349,435
|
$174,718
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-02
|
$487,558
|
$487,558
|
BADR, HODA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$7,486
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$25,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$857,699
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
The Oncogenic and Tumor Suppressor Functions of the Kras isoform 4A in vivo
|
1R01CA184089-01
|
$458,550
|
$458,550
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Genetic analysis of ras mutation specificity in skin and lung cancer
|
1R01CA184510-01A1
|
$361,997
|
$180,999
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The role of the Kras4A isoform in epithelial carcinogenesis
|
5R01CA111834-09
|
$256,027
|
$256,027
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Lung for this search: $255,783,067
|